Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment

Background: Epidermal growth factor (EGF) is a mitogen for hepatocytes, and plays a critical role in liver tissue regeneration. Many signaling pathways especially pathways that regulate the physiological processes such as tumor cells growth, differentiation, migration, apoptosis, and angiogenesis ha...

Full description

Bibliographic Details
Main Authors: Nilly Abdallah, Nourhan Selim, Lamia Mahmoud, Shaimaa Abdelkreem, Ahmed Ibrahim
Format: Article
Language:English
Published: Beni-Suef University, Faculty of Medicine 2022-04-01
Series:Egyptian Journal of Medical Research
Subjects:
Online Access:https://ejmr.journals.ekb.eg/article_236208_609874e03b0d46cae8cd2f6e3a3b5c89.pdf
_version_ 1797894021462360064
author Nilly Abdallah
Nourhan Selim
Lamia Mahmoud
Shaimaa Abdelkreem
Ahmed Ibrahim
author_facet Nilly Abdallah
Nourhan Selim
Lamia Mahmoud
Shaimaa Abdelkreem
Ahmed Ibrahim
author_sort Nilly Abdallah
collection DOAJ
description Background: Epidermal growth factor (EGF) is a mitogen for hepatocytes, and plays a critical role in liver tissue regeneration. Many signaling pathways especially pathways that regulate the physiological processes such as tumor cells growth, differentiation, migration, apoptosis, and angiogenesis had been studied in the era of HCC development such as the EGF signal pathway.During the past few years, there have been enormous efforts to understand the structure and life cycle of hepatitis C virus (HCV) as well as to develop specific medications targeting different viral proteins such as NS3/4A protease, NS5B polymerase, and NS5A replication complex. The discovery of direct acting antiviral agents (DAAs) represented a revolution in the management of chronic hepatitis C virus infection Objectives: to investigate polymorphism of the gene encoding EGF in HCV-induced liver cirrhosis whether receiving antiviral treatment or not.Methods: Sixty Egyptian patients were enrolled in the study. Twenty patients pre-diagnosed as HCV-induced liver cirrhosis and received antiviral treatment in the form of Daklatasvir, Sofosbuvir and Ribavirin for 3 months and sustained virological response (SVR) was obtained, 20 patients diagnosed as HCV-induced liver cirrhosis and not receiving treatment yet, and 20 healthy person of matched age and sex as control group). Genotyping for EGF gene was performed by real time PCR.Results: With regards to polymorphism of EGF gene there are three genotypes; A/A, A/G and G/G that were detected in the three studied groups. The frequency of EGF gene polymorphism in HCV patients who received treatment was (AA 5%, AG 60%, GG 35%), while was (AA10%, AG 45%, GG 45%) in HCV patients who did not receive treatment. In control group, the frequency was (AA 65 %, AG 15%, GG 20%). Upon examining the allelic discrimination, A allele was present in 35% of HCV patient who received treatment versus 32.5% of HCV patient who did not receive treatment and 72.5% of control group. On the other hand, G allele was present in 65% of HCV patients who received treatment versus 67.5% of HCV patients who did not receive treatment and 17.5% of control group. Conclusion: No significant effect of antiviral treatment on EGF gene.
first_indexed 2024-04-10T07:02:11Z
format Article
id doaj.art-e038189614034e25be717fe0fff0e2c6
institution Directory Open Access Journal
issn 2682-4396
2682-440X
language English
last_indexed 2024-04-10T07:02:11Z
publishDate 2022-04-01
publisher Beni-Suef University, Faculty of Medicine
record_format Article
series Egyptian Journal of Medical Research
spelling doaj.art-e038189614034e25be717fe0fff0e2c62023-02-27T17:41:48ZengBeni-Suef University, Faculty of MedicineEgyptian Journal of Medical Research2682-43962682-440X2022-04-01329710910.21608/ejmr.2022.236208236208Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without TreatmentNilly Abdallah0Nourhan Selim1Lamia Mahmoud2Shaimaa Abdelkreem3Ahmed Ibrahim4Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptClinical Pathology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptBackground: Epidermal growth factor (EGF) is a mitogen for hepatocytes, and plays a critical role in liver tissue regeneration. Many signaling pathways especially pathways that regulate the physiological processes such as tumor cells growth, differentiation, migration, apoptosis, and angiogenesis had been studied in the era of HCC development such as the EGF signal pathway.During the past few years, there have been enormous efforts to understand the structure and life cycle of hepatitis C virus (HCV) as well as to develop specific medications targeting different viral proteins such as NS3/4A protease, NS5B polymerase, and NS5A replication complex. The discovery of direct acting antiviral agents (DAAs) represented a revolution in the management of chronic hepatitis C virus infection Objectives: to investigate polymorphism of the gene encoding EGF in HCV-induced liver cirrhosis whether receiving antiviral treatment or not.Methods: Sixty Egyptian patients were enrolled in the study. Twenty patients pre-diagnosed as HCV-induced liver cirrhosis and received antiviral treatment in the form of Daklatasvir, Sofosbuvir and Ribavirin for 3 months and sustained virological response (SVR) was obtained, 20 patients diagnosed as HCV-induced liver cirrhosis and not receiving treatment yet, and 20 healthy person of matched age and sex as control group). Genotyping for EGF gene was performed by real time PCR.Results: With regards to polymorphism of EGF gene there are three genotypes; A/A, A/G and G/G that were detected in the three studied groups. The frequency of EGF gene polymorphism in HCV patients who received treatment was (AA 5%, AG 60%, GG 35%), while was (AA10%, AG 45%, GG 45%) in HCV patients who did not receive treatment. In control group, the frequency was (AA 65 %, AG 15%, GG 20%). Upon examining the allelic discrimination, A allele was present in 35% of HCV patient who received treatment versus 32.5% of HCV patient who did not receive treatment and 72.5% of control group. On the other hand, G allele was present in 65% of HCV patients who received treatment versus 67.5% of HCV patients who did not receive treatment and 17.5% of control group. Conclusion: No significant effect of antiviral treatment on EGF gene.https://ejmr.journals.ekb.eg/article_236208_609874e03b0d46cae8cd2f6e3a3b5c89.pdfhcv infectionliver cirrhosisepidermal growth factor genegene polymorphismegypt
spellingShingle Nilly Abdallah
Nourhan Selim
Lamia Mahmoud
Shaimaa Abdelkreem
Ahmed Ibrahim
Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment
Egyptian Journal of Medical Research
hcv infection
liver cirrhosis
epidermal growth factor gene
gene polymorphism
egypt
title Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment
title_full Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment
title_fullStr Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment
title_full_unstemmed Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment
title_short Study of Epidermal Growth Factor Gene Polymorphism in Hepatitis C Virus Induced Liver Cirrhosis with or without Treatment
title_sort study of epidermal growth factor gene polymorphism in hepatitis c virus induced liver cirrhosis with or without treatment
topic hcv infection
liver cirrhosis
epidermal growth factor gene
gene polymorphism
egypt
url https://ejmr.journals.ekb.eg/article_236208_609874e03b0d46cae8cd2f6e3a3b5c89.pdf
work_keys_str_mv AT nillyabdallah studyofepidermalgrowthfactorgenepolymorphisminhepatitiscvirusinducedlivercirrhosiswithorwithouttreatment
AT nourhanselim studyofepidermalgrowthfactorgenepolymorphisminhepatitiscvirusinducedlivercirrhosiswithorwithouttreatment
AT lamiamahmoud studyofepidermalgrowthfactorgenepolymorphisminhepatitiscvirusinducedlivercirrhosiswithorwithouttreatment
AT shaimaaabdelkreem studyofepidermalgrowthfactorgenepolymorphisminhepatitiscvirusinducedlivercirrhosiswithorwithouttreatment
AT ahmedibrahim studyofepidermalgrowthfactorgenepolymorphisminhepatitiscvirusinducedlivercirrhosiswithorwithouttreatment